Review Special Issues

Context-dependent interplay between Hippo and JNK pathway in Drosophila

  • Both Hippo and JNK signaling have well-established roles in regulating many physiological processes, including cell proliferation, growth, survival, and migration. An increasing body of evidence shows that dysregulation of either Hippo or JNK pathway would lead to tumorigenesis. Recently, studies in Drosophila has coupled Hippo with JNK pathway in numerous ways ranging from tissue regeneration to growth control. In this review, I provide an overview of the current understanding of crosstalk between Hippo and JNK pathway in Drosophila, and discuss their context-dependent interactions in gut homeostasis, regeneration, cell competition and migration.

    Citation: Xianjue Ma. Context-dependent interplay between Hippo and JNK pathway in Drosophila[J]. AIMS Genetics, 2014, 1(1): 20-33. doi: 10.3934/genet.2014.1.20

    Related Papers:

    [1] Tin Tin Su . Non-autonomous consequences of cell death and other perks of being metazoan. AIMS Genetics, 2015, 2(1): 54-69. doi: 10.3934/genet.2015.1.54
    [2] Jue Er Amanda Lee, Linda May Parsons, Leonie M. Quinn . MYC function and regulation in flies: how Drosophila has enlightened MYC cancer biology. AIMS Genetics, 2014, 1(1): 81-98. doi: 10.3934/genet.2014.1.81
    [3] Carlos Estella, Antonio Baonza . Cell proliferation control by Notch signalling during imaginal discs development in Drosophila. AIMS Genetics, 2015, 2(1): 70-96. doi: 10.3934/genet.2015.1.70
    [4] Michael J. Murray . Drosophila models of metastasis. AIMS Genetics, 2015, 2(1): 25-53. doi: 10.3934/genet.2015.1.25
    [5] John E. La Marca, Wayne Gregory Somers . The Drosophila gonads: models for stem cell proliferation, self-renewal, and differentiation. AIMS Genetics, 2014, 1(1): 55-80. doi: 10.3934/genet.2014.1.55
    [6] Francesca Froldi, Milán Szuperák, Louise Y. Cheng . Neural stem cell derived tumourigenesis. AIMS Genetics, 2015, 2(1): 13-24. doi: 10.3934/genet.2015.1.13
    [7] Dawei Liu, Zeeshan Shaukat, Rashid Hussain, Mahwish Khan, Stephen L. Gregory . Drosophila as a model for chromosomal instability. AIMS Genetics, 2015, 2(1): 1-12. doi: 10.3934/genet.2015.1.1
    [8] Helena E. Richardson . Drosophila models of cancer. AIMS Genetics, 2015, 2(1): 97-103. doi: 10.3934/genet.2015.1.97
    [9] Xiaochen Fan, David A F Loebel, Heidi Bildsoe, Emilie E Wilkie, Jing Qin, Junwen Wang, Patrick P L Tam . Tissue interactions, cell signaling and transcriptional control in the cranial mesoderm during craniofacial development. AIMS Genetics, 2016, 3(1): 74-98. doi: 10.3934/genet.2016.1.74
    [10] Michael T. Fasullo, Mingzeng Sun . Both RAD5-dependent and independent pathways are involved in DNA damage-associated sister chromatid exchange in budding yeast. AIMS Genetics, 2017, 4(2): 84-102. doi: 10.3934/genet.2017.2.84
  • Both Hippo and JNK signaling have well-established roles in regulating many physiological processes, including cell proliferation, growth, survival, and migration. An increasing body of evidence shows that dysregulation of either Hippo or JNK pathway would lead to tumorigenesis. Recently, studies in Drosophila has coupled Hippo with JNK pathway in numerous ways ranging from tissue regeneration to growth control. In this review, I provide an overview of the current understanding of crosstalk between Hippo and JNK pathway in Drosophila, and discuss their context-dependent interactions in gut homeostasis, regeneration, cell competition and migration.


    1. Introduction

    1.1. The Hippo signaling pathway

    The Hippo pathway was initially identified by genetic screens for growth regulating genes in Drosophila melanogaster. Recent studies have uncovered its function as a highly conserved tumor-suppressor pathway which plays essential roles in regulating multiple aspects of tumorigenesis, including cell growth, proliferation and survival [1,2,3]. The first identified four core components of Hippo pathway are the NDR family kinase Warts (Wts), the Ste20-like family kinase Hippo (Hpo), the WW-domain containing protein Salvador (Sav), and the adaptor protein Mob-as-tumor-suppressor (Mts) [4,5,6,7,8,9,10,11,12]. Hpo complexes with Sav to phosphorylate and activate Wts, which in turn, in conjunction with Mts, directly phosphorylates the transcriptional co-activator Yorkie (Yki), resulting in its cytoplasmic accumulation and activity inhibition [9,13,14]. Once the Hippo pathway is deactivated, Yki can translocate into nucleus to partner with different DNA-binding transcription factors, including the TEAD/TEF family transcription factor Scalloped (Sd) [15,16,17], to activate the transcription of many cell growth and viability regulating genes, such as cyclin E (cycE), expanded (ex) and Drosophila inhibitor of apoptosis protein 1 (diap1) [1,3]. In short, cells with reduced Hippo signal or increased Yki activity overgrowth [1,4,5,6,7,8,9,10,11,12,13]. So far, over 20 Hippo pathway regulators have been identified in Drosophila [18], and overwhelming evidence in mammals has further confirmed their conserved roles in regulating tumorigenesis and cancer development [2,19,20].

    1.2. The JNK signaling pathway

    The c-Jun N-terminal Kinase (JNK) pathway represents another key conserved eukaryotic signaling pathway. Initially identified as a stress-activated protein kinase (SAPK) [21], JNK can be activated by various stimuli ranging from UV irradiation to DNA damage, bacterial infection, and cytokines [22,23]. Upon stimulation, JNK will be activated by the mitogen-activated protein (MAP) phosphorylation kinase cascade composed of different members of JNK Kinase Kinases and JNK Kinases (JNKKKs JNKKs JNKs) [23]. Then JNK translocates into the nucleus to phosphorylate and activate the prototypical transcription factors including AP-1 family members Jun and Fos [24]. In Drosophila, the JNK pathway is much simpler than in mammals, with only a single JNK (Basket, Bsk) and two JNKKs (Hemipterous, Hep and MKK4) [25]. In the past 18 years, increasing studies have revealed that JNK pathway is involved in a wide range of cellular processes including proliferation, cell competition, regeneration, survival and tumor progression [23,26,27]. Notably, unlike Hippo pathway, recent studies in Drosophila discovered that JNK activation can lead to tumor suppression or tumor progression depending on the context [28,29,30], which will be discussed in this review.

    2. Crosstalk between Hippo and JNK signaling

    2.1. Gut homeostasis and regeneration

    Drosophila gut is under constant attack due to exposure to different pathogens and chemical stimuli during normal feeding. In order to maintain gut homeostasis, intestine stem cell (ISC) proliferation is required to ensure the replenishment of damaged cells [31,32], while disruption of this process would cause diseases including cancer [33]. Drosophila midgut epithelia is mainly composed of four cell types, namely ISC, enteroblast (EB) cells, absorptive enterocyte (EC) cells, and secretory enteroendocrine (ee) cells. The ISC division gives rise to a new ISC and enteroblast, the later further differentiates into either an absorptive enterocyte or a secretory enteroendocrine cell, based on the level of Notch signaling [34]. For the past decade, extensive studies using Drosophila midgut have uncovered a signaling network that maintains the homeostasis of gut epithelia, including Hippo and JNK pathway [35].

    As a major stress sensor, JNK can be activated both in EC and ISC by bacterial infection or DNA damage to stimulate non-autonomous and autonomous ISC proliferation, respectively [36,37,38,39,40]. In the EC cells, JNK activation via Puc (a phosphatase which inhibits JNK activity) RNAi or Hep overexpression increased ISC mitosis [38] and resulted in nuclear Yki translocation and Hpo target genes expression [36,41], which could further trigger secretion of the Unpaired (Upd) cytokines to drive non-autonomous ISC proliferation through JAK/STAT signaling pathway (Figure 1) [36,40,41]. Moreover, JNK activation in the progenitor cells of Drosophila midgut is sufficient to upregulate Wg expression, which in turn induces Myc-dependent ISC renewal (Figure 1) [42].

    Figure 1. Crosstalk of JNK and Hippo signaling during Drosophila midgut regeneration. Upon damage or bacterial infection, JNK signaling acts autonomously in ECs and acts non-autonomously in ISC to stimulate regeneration through Hippo pathway inactivation. See text for details. Abbreviations: ISC, intestinal stem cell; EC, enterocyte; EB, enteroblast; ee, enteroendocrine cell; Wg, Wingless.

    In addition, JNK and Hippo signaling have also been shown to regulate ISC proliferation in an autonomous manner [39,40,41,43]. Reducing JNK activity within ISCs significantly blocked Ecc15 (Erwinia carotovora carotovora 15, Gram-negative bacteria) infection and paraquat-induced proliferation [37,44], whereas ectopic JNK activation by Hep or Rac1 (small GTPase acting upstream of JNK) overexpression promoted ISC self-renewal [39,45]. Similarly, silencing yki reduced excessive ISC proliferation induced by Gram-negative bacteria Pseudomonas entomophila (P. e) [41], while inactivation of Hippo signaling had an opposite effect [40,41]. Additionally, Ren and colleagues recently identified Myc as a crucial integrator of multiple signaling including Hippo and JAK/STAT in ISC regeneration (Figure 1) [46]. Importantly, unlike Myc, neither Yki nor JNK inhibition reduced ISC number under normal condition [36,43,44,46], highlighting their essential role as stress sensors in gut epithelia.

    2.2. Regeneration in wing disc

    JNK signaling activation has been considered as a universal hallmark of regenerating tissue in response to damage [47,48,49]. Besides, it is also shown that JNK plays critical roles in apoptosis-induced non-autonomous compensatory proliferation [50], which could accelerate the regeneration process. Two recent studies revealed that Hippo pathway also regulates regenerative growth in Drosophila wing disc. They found that Yki functions as a pivotal determinant for regeneration, as removing only one copy of yki could dramatically impair regenerating ability, while does not affect normal wing development [51,52]. Furthermore, activation of JNK by ectopic expression of Eiger (Egr, the Drosophila TNF homolog) or HepCA (a constitutive form of Hep) could induce Yki nuclear accumulation and target gene expression, both autonomously and non-autonomously [51,52]. In the former situation, JNK upregulates Wg secretion as well as Yki target gene expression, while it simultaneously triggers extensive cell death which may counteract the Yki induced growth advantage. In the latter scenario, JNK might propagate into neighboring cells [53] to induce non-autonomous compensatory proliferation via activation of Yki, Wg, Dpp, and Myc [18,50,51,54].

    2.3. Cell competition

    The phenomenon “cell competition” was first discovered in mosaic Drosophila proliferating wing epithelia [55], in which the faster growing cells (winner) would outcompete the slower growing cells (loser) via inducing apoptosis [56,57]. It is known that both JNK and Hippo pathway play essential roles in regulating cell competition [58,59], while not until recently, studies in fly have provided a link between cell competition and Hippo, JNK signaling [60,61,62,63].

    2.3.1. Cell competition as tumor suppressor

    The discovery of cell competition raised a key question: what is the physiological function of cell competition? Given the fact that around 85% of cancer arise from mutated epithelia cells (Cancerstats), cell competition has been rationally assumed as an intrinsic tumor suppressing mechanism removing “unwanted” cells to maintain normal tissue homeostasis [57]. Consistent with this hypothesis, mutant clones generated in Drosophila wing epithelium which lost the neoplastic tumor suppressor genes, including lethal (2) giant larvae (l(2)gl), discs large (dlg) or scribble (scrib), would be eliminated by JNK-dependent apoptosis or engulfment by neighboring wild-type cells (Figure 2A) [30,60,61,62,64,65,66,67]. Interestingly, Froldi et al found that l(2)gl−/− clones express relative low levels of Myc compared to surrounding wild-type tissue [67]. Since Myc was recently identified as a direct target of Yki [68,69], and plays essential roles in cell competition and growth control [70,71], hence it is highly possible cell polarity disruption is related with Yki-Myc activation during cell competition (Figure 2A). Strikingly, it is also reported that in spite of facing cell competition, scrib−/− clones can induce non-autonomous Yki activation in neighboring cells [51], which may further accelerate the elimination of scrib−/− clones.

    Figure 2. JNK and Hippo context-dependent interactions during cell competition. (A) scrib−/− cells are eliminated by wild-type neighboring cells. (B) scrib−/− cells with JNK inhibition induces Yki-mediated tumor growth. (C) Src64B overexpression clones causes non-autonomous overgrowth of surrounding tissue. (D) Blocking JNK signaling in Src-expressing clones releases inhibition of Yki activity and results in autonomous growth. (E) RasV12 expression turn scrib−/− cells into super-competitor by activating both Yki and JNK. (F) Hippo inactivation upregulates Rho1-JNK signaling to induce autonomous growth and super-competitor behavior.

    Several recent studies demonstrated that scrib−/− clones indeed have a hyper-proliferate potential, which however was dramatically inhibited by JNK activity [28,62,64,72,73]. When scrib−/− clones were protected from cell competition via expression of BskDN (a dominant negative form of Drosophila JNK, Bsk), they can ectopically proliferate and induce Yki target genes expression [62,72], in Sd/Yki-dependent manner [72]. Consistently, overexpression of Yki or Myc is sufficient to rescue scrib−/− clones from being outcompeted [62]. Therefore, Yki level in scrib−/− clones is an essential determinant of whether they would be outcompeted or became super-competitors when JNK signaling is dysregulated (Figure 2B).

    Another intriguing question focusing on cell competition is how the loser cells were marked? A recent study shed lights on this puzzle [74]. The transmembrane protein Flower encodes three different isoforms, two of which are only detected in loser cells facing competition. Knocking down those two flower isoforms protected the losers from being outcompeted, and conversely, overexpression of them would lead to apoptosis and elimination. It would be worthwhile to further investigate whether Flower-induced competition also operates in a JNK- or Yki-dependent manner (Figure 2A).

    Remarkably, it is also reported that unlike scrib, depletion of l(2)gl in eye epithelial alone is sufficient to suppress Hpo pathway activity, resulting in mild proliferation and Yki activation [75]. Similarly, blocking JNK via expression of Puc in l(2)gl−/− cells did not produce tumor growth phenotype in wing epithelia, even though apoptosis was abolished [60].

    2.3.2. Cell competition in promoting tumor progression

    Interestingly, Enomoto and Igaki recently found that loser clones expressing oncoprotein Src64B could contribute to proliferation of surrounding winner cells, which also rely on both JNK and Hippo signaling [63]. Src64B overexpression clones have increased JNK activity, leading to their elimination by cell competition, while at the same time, JNK induces dramatic non-autonomous growth via Yki activation in neighboring cells (Figure 2C). Conversely, inhibiting JNK activity within Src64B overexpression clones not only blocked the non-autonomous overgrowth of surrounding tissue, but also results in autonomous proliferation and Yki hyperactivation (Figure 2D), highlighting anti-Yki effects of JNK activation in the presence of Src64B. However, the mechanism of how Src64B switches its functions from JNK-dependent pro-Yki to anti-Yki remains unknown. Hence, in addition to the tumor-suppressing role, cell competition could also act as a tumor-promoting factor, promoting JNK activation and subsequently Yki-mediated proliferation of neighboring cell. In accordance with this view, a recent study in Drosophila showed that cell competition could possess both tumor-suppressing and tumor-inducing roles depending on the population of loser cells [76].

    2.3.3. RasV12 hijacks scrib−/− clones into super-competitors

    Apart from the pro-apoptotic role discussed above, JNK pathway can promote oncogenic transformation and tumorigenesis as well [23,28,77,78]. In the Drosophila antennal-eye disc, expression of oncogenic Ras (RasV12) could convert loser scrib−/− clones into super-competitors with massive overgrowth and proliferation [64,79]. Both JNK and Hippo pathways are essential for scrib−/−/RasV12 cooperation-induced growth, as reducing either JNK or Yki activity would be sufficient to block tumor growth (Figure 2E) [29,60,72,78]. By using eye epithelia as a model, Ohsawa and colleagues found JNK activation (via Egr overexpression) could cooperate with RasV12 to autonomously activate Yki target genes expression, including diap1 and cycE, indicating a pro-Yki activity of JNK in the presence of RasV12 [77]. Wu and colleagues investigated the cooperation between scrib−/− and RasV12 clones in both intra- and interclonal situations, and revealed a JNK-dependent upregulation of upd, which accelerated both tumor growth and metastasis [53]. In accordance with this genetic data, clones lacking JAK/STAT activity would be eliminated without JNK activation [80]. In consideration of the epistasis data obtained from Hippo and JAK/STAT signaling in Drosophila intestine homeostasis [40,41,43], it is highly possible that Yki may play essential roles in linking scrib−/−/RasV12 induced tumor growth and JAK/STAT activation (Figure 2E). Moreover, in addition to autonomous proliferation observed in scrib−/−/RasV12 clones, a non-autonomous effect on Hippo signaling was also seen in surrounding neighbors [62], probably owing to JNK propagation and subsequent compensatory proliferation [53].

    In summary, the evidence outlined above indicates that in Drosophila JNK can have both pro- and anti-Yki function depending on the context, highlighting the importance for a further understanding of the regulatory crosstalk between Hippo and JNK in developing potential therapeutic treatments of different cancers.

    2.3.4. Yki super-competitor property requires JNK activity

    Missing core components of Hippo pathway or Yki overexpression are sufficient to turn clones into super-competitors via autonomous proliferation and induction of cell death in surrounding wild-type neighbors [60,68]. Apart from the involvement of Myc-mediated cell competition [68], our recent study provide a further mechanistic insight into the overgrowth properties caused by Hippo signaling loss (unpublished data, Figure 2F). By using Drosophila wing epithelia as a model, we found that impaired Hpo pathway activates JNK signaling in vivo and JNK activity is essential for Yki-induced growth and proliferation. Furthermore, we identified rho1 as a direct transcriptional target of Yki/Sd complex. In agreement with previous studies [81,82], we found Rho1 overexpression promotes growth when cell death is compromised. Finally, we also demonstrate that the mammalian YAP is also able to activate rho1 transcription and JNK activation in Sd-dependent manner when expressed in Drosophila, indicating a likely conserved role of Yap in regulating Rho1-JNK mediated growth in mammals (Figure 2F). Thus, our study reveals a novel means of crosstalk between Hippo and JNK signaling.

    2.4. Ajuba links Hippo to JNK signaling

    The direct evidence illuminating Hippo and JNK interaction came from a recent study by Sun and Irvine [83]. They found HepCA overexpression in the Drosophila wing epithelia can induce Yki nuclear accumulation and target gene expression, which were dramatically suppressed by activating Hippo pathway (Hpo or Wts overexpression). Their epitasis analysis further identified that Ajuba LIM protein (Jub), which has been shown to interact with Wts [84], functions as a bridge mediating Yorkie activation by JNK. Moreover, JNK can directly phosphorylate the mammalian Ajuba family protein LIMD1 and enhance its binding to LATS (Wts homolog in mammal), indicating a conserved role of JNK-Ajuba-Hippo signaling in mammalian cells.

    2.5. Cell invasion and migration

    Apart from regulating tumor growth and cell competition, JNK pathway also plays critical roles in cell invasion and migration [64,79,85]. For the past decade, Drosophila has been used extensively as an excellent model to investigate the mechanism of tumor invasion and metastasis [86,87,88]. Metastasis begins with the local invasion of tumor cells [89], and in Drosophila eye antennal discs, expression of RasV12 can cooperate with mutants that simultaneously disrupt apical-basal cell polarity to induce invasive tumors into the ventral nerve cord (VNC) [64,79], while subsequent studies showed this invasion requires numerous JNK pathway components [78,85,90,91,92]. Despite the well documented role of Yap in promoting invasion [2,93], it is found that in Drosophila Yki activity is dispensable for invasive behavior of scrib−/−/RasV12 tumors, nevertheless the tumor size is significantly reduced [72]. Similarly, JNK activation specifically along the anterior/posterior boundary of wing disc is sufficient to induce cell invasion phenotype [85,94], while overexpression of Yki cannot [95], despite the dramatic upregulation of MMP1 (unpublished data), a protein required for basement membrane degradation and cell invasion [85,96]. Remarkably, Yuan and colleagues found that Yap actually can function as a negative regulator of invasion in breast cancer [97], they observed reduced Yap protein level in breast cancer sample and reducing Yap activity significantly increased cell migration and invasion. In accordance with this view, studies using Drosophila oocyte found that loss of Hippo activity (generating hpo−/− or wts−/− clones) markedly impeded border cell migration during oogenesis [98,99], phenocopying JNK loss-induced defects [100]. Given the complicated and context-dependent crosstalk between JNK and Hippo signaling (see above), it would be quite interesting to further investigate their corresponding roles in cell invasion and migration both in fly and mammal.

    Recent studies in Drosophila also linked mechanical tension to Hippo and JNK signaling in tumor progression and invasive migration [101,102,103]. Cheerio (Cher/Filamin), an actin cross-linking protein, was found to be enriched in a JNK-dependent manner in invasive scrib−/−/RasV12 tumors [101]. Loss of cher not only dramatically impeded scrib−/−/RasV12 induced tumor growth and invasion, but also enabled larvae to form pupae [101], in contrast to scrib−/−/RasV12 tumor-bearing animals that mostly die as giant larvae [64,79]. In addition, it is also revealed that inhibiton of cher, but not JNK signaling, suppressed Yki target gene elevation in the scrib−/−/RasV12 clones [101], however the mechanism of how Cher interacts with Hippo pathway remains unknown. In another study, Fernandez and colleagues showed that in the wing epithelia, actin-Capping Protein (CP) could antagonize oncoprotein Src64B induced overgrowth by restricting JNK signaling, and they also found Src64B upregulated Yki target genes expression via JNK, supporting a pro-Yki activity of JNK signaling [103]. Yet, whether and how JNK and Hippo signaling are coordinated in tumor invasion remains to be further addressed.

    3. Conclusion

    Both JNK and Hippo pathway regulate various essential biological processes including cell survival, growth and regeneration, and deregulation of either pathway is associated with cancer development in human [2,104]. For the past decade, thanks to the elegant genetic screen performed in Drosophila, a complex network composed of numerous novel components of Hippo and JNK pathway has been established, which shed lights on the treatment of related human cancers. JNK signaling integrates with Hippo signaling in a context dependent manner (this review), and increasing studies show that both pathway possess components that are potential attractive drug targets for cancer treatment [105,106]. Thus, more comprehensive work is clearly needed to further address the regulatory mechanism between JNK and Hippo in diverse physiological functions in vivo. Moreover, given that studies have overwhelmingly proven that Drosophila can be an excellent drug screening model [107,108], it is promising to expect that the small fruit fly will make important contributions to the pharmaceutical intervention of Hippo and JNK related cancers.

    Acknowledgements

    I am grateful for Dr. Lei Xue for guidance and valuable advice, Dr. Tatsushi Igaki for personal communication, Dr. Yonggang Zheng for critical reading of the manuscript and helpful comments. I apologize to all the researchers whose work I have not cited due to space limitations.

    Conflict of Interest

    Authordeclares no conflicts of interest in this paper.

    [1] Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505. doi: 10.1016/j.devcel.2010.09.011
    [2] Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13: 246-257. doi: 10.1038/nrc3458
    [3] Pan D (2007) Hippo signaling in organ size control. Genes Dev 21: 886-897. doi: 10.1101/gad.1536007
    [4] Xu T, Wang W, Zhang S, et al. (1995) Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121: 1053-1063.
    [5] Justice RW, Zilian O, Woods DF, et al. (1995) The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534-546. doi: 10.1101/gad.9.5.534
    [6] Tapon N, Harvey KF, Bell DW, et al. (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467-478. doi: 10.1016/S0092-8674(02)00824-3
    [7] Kango-Singh M, Nolo R, Tao C, et al. (2002) Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129: 5719-5730. doi: 10.1242/dev.00168
    [8] Harvey KF, Pfleger CM, Hariharan IK (2003) The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114: 457-467. doi: 10.1016/S0092-8674(03)00557-9
    [9] Wu S, Huang J, Dong J, et al. (2003) hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456. doi: 10.1016/S0092-8674(03)00549-X
    [10] Udan RS, Kango-Singh M, Nolo R, et al. (2003) Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5: 914-920. doi: 10.1038/ncb1050
    [11] Pantalacci S, Tapon N, Leopold P (2003) The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5: 921-927. doi: 10.1038/ncb1051
    [12] Lai ZC, Wei X, Shimizu T, et al. (2005) Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685. doi: 10.1016/j.cell.2004.12.036
    [13] Huang J, Wu S, Barrera J, et al. (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434. doi: 10.1016/j.cell.2005.06.007
    [14] Oh H, Irvine KD (2008) In vivo regulation of Yorkie phosphorylation and localization. Development 135: 1081-1088. doi: 10.1242/dev.015255
    [15] Wu S, Liu Y, Zheng Y, et al. (2008) The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14: 388-398. doi: 10.1016/j.devcel.2008.01.007
    [16] Zhang L, Ren F, Zhang Q, et al. (2008) The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 14: 377-387. doi: 10.1016/j.devcel.2008.01.006
    [17] Goulev Y, Fauny JD, Gonzalez-Marti B, et al. (2008) SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 18: 435-441. doi: 10.1016/j.cub.2008.02.034
    [18] Staley BK, Irvine KD (2012) Hippo signaling in Drosophila: recent advances and insights. Dev Dyn 241: 3-15. doi: 10.1002/dvdy.22723
    [19] Yu FX, Guan KL (2013) The Hippo pathway: regulators and regulations. Genes Dev 27: 355-371. doi: 10.1101/gad.210773.112
    [20] Mo JS, Park HW, Guan KL (2014) The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep 15: 642-656.
    [21] Kyriakis JM, Avruch J (1990) pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J Biol Chem 265: 17355-17363.
    [22] Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252. doi: 10.1016/S0092-8674(00)00116-1
    [23] Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149. doi: 10.1016/j.ceb.2007.02.001
    [24] Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157.
    [25] Igaki T (2009) Correcting developmental errors by apoptosis: lessons from Drosophila JNK signaling. Apoptosis 14: 1021-1028. doi: 10.1007/s10495-009-0361-7
    [26] Chen F (2012) JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 72: 379-386. doi: 10.1158/0008-5472.CAN-11-1982
    [27] Rios-Barrera LD, Riesgo-Escovar JR (2013) Regulating cell morphogenesis: the Drosophila Jun N-terminal kinase pathway. Genesis 51: 147-162. doi: 10.1002/dvg.22354
    [28] Uhlirova M, Jasper H, Bohmann D (2005) Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci U S A 102: 13123-13128. doi: 10.1073/pnas.0504170102
    [29] Cordero JB, Macagno JP, Stefanatos RK, et al. (2010) Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev Cell 18: 999-1011. doi: 10.1016/j.devcel.2010.05.014
    [30] Igaki T, Pastor-Pareja JC, Aonuma H, et al. (2009) Intrinsic tumor suppression and epithelial maintenance by endocytic activation of Eiger/TNF signaling in Drosophila. Dev Cell 16: 458-465. doi: 10.1016/j.devcel.2009.01.002
    [31] Kux K, Pitsouli C (2014) Tissue communication in regenerative inflammatory signaling: lessons from the fly gut. Front Cell Infect Microbiol 4: 49.
    [32] Amcheslavsky A, Jiang J, Ip YT (2009) Tissue damage-induced intestinal stem cell division in Drosophila. Cell Stem Cell 4: 49-61. doi: 10.1016/j.stem.2008.10.016
    [33] Apidianakis Y, Rahme LG (2011) Drosophila melanogaster as a model for human intestinal infection and pathology. Dis Model Mech 4: 21-30. doi: 10.1242/dmm.003970
    [34] Ohlstein B, Spradling A (2007) Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential notch signaling. Science 315: 988-992. doi: 10.1126/science.1136606
    [35] Lucchetta EM, Ohlstein B (2012) The Drosophila midgut: a model for stem cell driven tissue regeneration. Wiley Interdiscip Rev Dev Biol 1: 781-788. doi: 10.1002/wdev.51
    [36] Staley BK, Irvine KD (2010) Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 20: 1580-1587. doi: 10.1016/j.cub.2010.07.041
    [37] Buchon N, Broderick NA, Chakrabarti S, et al. (2009) Invasive and indigenous microbiota impact intestinal stem cell activity through multiple pathways in Drosophila. Genes Dev 23: 2333-2344. doi: 10.1101/gad.1827009
    [38] Jiang H, Patel PH, Kohlmaier A, et al. (2009) Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell 137: 1343-1355. doi: 10.1016/j.cell.2009.05.014
    [39] Biteau B, Hochmuth CE, Jasper H (2008) JNK activity in somatic stem cells causes loss of tissue homeostasis in the aging Drosophila gut. Cell Stem Cell 3: 442-455. doi: 10.1016/j.stem.2008.07.024
    [40] Ren F, Wang B, Yue T, et al. (2010) Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci U S A 107: 21064-21069. doi: 10.1073/pnas.1012759107
    [41] Shaw RL, Kohlmaier A, Polesello C, et al. (2010) The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 137: 4147-4158. doi: 10.1242/dev.052506
    [42] Cordero JB, Stefanatos RK, Scopelliti A, et al. (2012) Inducible progenitor-derived Wingless regulates adult midgut regeneration in Drosophila. EMBO J 31: 3901-3917. doi: 10.1038/emboj.2012.248
    [43] Karpowicz P, Perez J, Perrimon N (2010) The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 137: 4135-4145. doi: 10.1242/dev.060483
    [44] Biteau B, Jasper H (2011) EGF signaling regulates the proliferation of intestinal stem cells in Drosophila. Development 138: 1045-1055. doi: 10.1242/dev.056671
    [45] Myant KB, Scopelliti A, Haque S, et al. (2013) Rac1 drives intestinal stem cell proliferation and regeneration. Cell Cycle 12: 2973-2977. doi: 10.4161/cc.26031
    [46] Ren F, Shi Q, Chen Y, et al. (2013) Drosophila Myc integrates multiple signaling pathways to regulate intestinal stem cell proliferation during midgut regeneration. Cell Res 23: 1133-1146. doi: 10.1038/cr.2013.101
    [47] Worley MI, Setiawan L, Hariharan IK (2012) Regeneration and transdetermination in Drosophila imaginal discs. Annu Rev Genet 46: 289-310. doi: 10.1146/annurev-genet-110711-155637
    [48] Bergantinos C, Corominas M, Serras F (2010) Cell death-induced regeneration in wing imaginal discs requires JNK signalling. Development 137: 1169-1179. doi: 10.1242/dev.045559
    [49] Bosch M, Serras F, Martin-Blanco E, et al. (2005) JNK signaling pathway required for wound healing in regenerating Drosophila wing imaginal discs. Dev Biol 280: 73-86. doi: 10.1016/j.ydbio.2005.01.002
    [50] Ryoo HD, Gorenc T, Steller H (2004) Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 7: 491-501. doi: 10.1016/j.devcel.2004.08.019
    [51] Grusche FA, Degoutin JL, Richardson HE, et al. (2011) The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev Biol 350: 255-266. doi: 10.1016/j.ydbio.2010.11.020
    [52] Sun G, Irvine KD (2011) Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol 350: 139-151. doi: 10.1016/j.ydbio.2010.11.036
    [53] Wu M, Pastor-Pareja JC, Xu T (2010) Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 463: 545-548. doi: 10.1038/nature08702
    [54] Smith-Bolton RK, Worley MI, Kanda H, et al. (2009) Regenerative growth in Drosophila imaginal discs is regulated by Wingless and Myc. Dev Cell 16: 797-809. doi: 10.1016/j.devcel.2009.04.015
    [55] Morata G, Ripoll P (1975) Minutes: mutants of drosophila autonomously affecting cell division rate. Dev Biol 42: 211-221. doi: 10.1016/0012-1606(75)90330-9
    [56] Levayer R, Moreno E (2013) Mechanisms of cell competition: themes and variations. J Cell Biol 200: 689-698. doi: 10.1083/jcb.201301051
    [57] Vincent JP, Fletcher AG, Baena-Lopez LA (2013) Mechanisms and mechanics of cell competition in epithelia. Nat Rev Mol Cell Biol 14: 581-591. doi: 10.1038/nrm3639
    [58] Tyler DM, Li W, Zhuo N, et al. (2007) Genes affecting cell competition in Drosophila. Genetics 175: 643-657. doi: 10.1534/genetics.106.061929
    [59] Moreno E, Basler K, Morata G (2002) Cells compete for decapentaplegic survival factor to prevent apoptosis in Drosophila wing development. Nature 416: 755-759. doi: 10.1038/416755a
    [60] Menendez J, Perez-Garijo A, Calleja M, et al. (2010) A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc Natl Acad Sci U S A 107: 14651-14656. doi: 10.1073/pnas.1009376107
    [61] Grzeschik NA, Parsons LM, Richardson HE (2010) Lgl, the SWH pathway and tumorigenesis: It's a matter of context & competition! Cell Cycle 9: 3202-3212.
    [62] Chen CL, Schroeder MC, Kango-Singh M, et al. (2012) Tumor suppression by cell competition through regulation of the Hippo pathway. Proc Natl Acad Sci U S A 109: 484-489. doi: 10.1073/pnas.1113882109
    [63] Enomoto M, Igaki T (2013) Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in Drosophila. EMBO Rep 14: 65-72. doi: 10.1038/embor.2012.185
    [64] Brumby AM, Richardson HE (2003) scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J 22: 5769-5779. doi: 10.1093/emboj/cdg548
    [65] Tamori Y, Bialucha CU, Tian AG, et al. (2010) Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol 8: e1000422. doi: 10.1371/journal.pbio.1000422
    [66] Ohsawa S, Sugimura K, Takino K, et al. (2011) Elimination of oncogenic neighbors by JNK-mediated engulfment in Drosophila. Dev Cell 20: 315-328. doi: 10.1016/j.devcel.2011.02.007
    [67] Froldi F, Ziosi M, Garoia F, et al. (2010) The lethal giant larvae tumour suppressor mutation requires dMyc oncoprotein to promote clonal malignancy. BMC Biol 8: 33. doi: 10.1186/1741-7007-8-33
    [68] Ziosi M, Baena-Lopez LA, Grifoni D, et al. (2010) dMyc Functions Downstream of Yorkie to Promote the Supercompetitive Behavior of Hippo Pathway Mutant Cells. PLoS Genet 6: e1001140. doi: 10.1371/journal.pgen.1001140
    [69] Neto-Silva RM, de Beco S, Johnston LA (2010) Evidence for a Growth-Stabilizing Regulatory Feedback Mechanism between Myc and Yorkie, the Drosophila Homolog of Yap. Dev Cell 19: 507-520. doi: 10.1016/j.devcel.2010.09.009
    [70] Moreno E, Basler K (2004) dMyc transforms cells into super-competitors. Cell 117: 117-129. doi: 10.1016/S0092-8674(04)00262-4
    [71] Grifoni D, Bellosta P (2014) Drosophila Myc: A master regulator of cellular performance. Biochim Biophys Acta.
    [72] Doggett K, Grusche FA, Richardson HE, et al. (2011) Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling. BMC Dev Biol 11: 57. doi: 10.1186/1471-213X-11-57
    [73] Leong GR, Goulding KR, Amin N, et al. (2009) Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs. BMC Biol 7: 62. doi: 10.1186/1741-7007-7-62
    [74] Rhiner C, Lopez-Gay JM, Soldini D, et al. (2010) Flower forms an extracellular code that reveals the fitness of a cell to its neighbors in Drosophila. Dev Cell 18: 985-998. doi: 10.1016/j.devcel.2010.05.010
    [75] Grzeschik NA, Parsons LM, Allott ML, et al. (2010) Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20: 573-581. doi: 10.1016/j.cub.2010.01.055
    [76] Ballesteros-Arias L, Saavedra V, Morata G (2014) Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila. Oncogene 33: 4377-4384. doi: 10.1038/onc.2013.407
    [77] Ohsawa S, Sato Y, Enomoto M, et al. (2012) Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Nature 490: 547-551. doi: 10.1038/nature11452
    [78] Igaki T, Pagliarini RA, Xu T (2006) Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 16: 1139-1146. doi: 10.1016/j.cub.2006.04.042
    [79] Pagliarini RA, Xu T (2003) A genetic screen in Drosophila for metastatic behavior. Science 302: 1227-1231. doi: 10.1126/science.1088474
    [80] Rodrigues AB, Zoranovic T, Ayala-Camargo A, et al. (2012) Activated STAT regulates growth and induces competitive interactions independently of Myc, Yorkie, Wingless and ribosome biogenesis. Development 139: 4051-4061. doi: 10.1242/dev.076760
    [81] Brumby AM, Goulding KR, Schlosser T, et al. (2011) Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis. Genetics 188: 105-125. doi: 10.1534/genetics.111.127910
    [82] Khoo P, Allan K, Willoughby L, et al. (2013) In Drosophila, RhoGEF2 cooperates with activated Ras in tumorigenesis through a pathway involving Rho1-Rok-Myosin-II and JNK signalling. Dis Model Mech 6: 661-678. doi: 10.1242/dmm.010066
    [83] Sun G, Irvine KD (2013) Ajuba family proteins link JNK to Hippo signaling. Sci Signal 6: ra81.
    [84] Das Thakur M, Feng Y, Jagannathan R, et al. (2010) Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol 20: 657-662.
    [85] Uhlirova M, Bohmann D (2006) JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J 25: 5294-5304. doi: 10.1038/sj.emboj.7601401
    [86] Miles WO, Dyson NJ, Walker JA (2011) Modeling tumor invasion and metastasis in Drosophila. Dis Model Mech 4: 753-761. doi: 10.1242/dmm.006908
    [87] Willoughby LF, Schlosser T, Manning SA, et al. (2013) An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery. Dis Model Mech 6: 521-529. doi: 10.1242/dmm.009985
    [88] Pastor-Pareja JC, Xu T (2013) Dissecting Social Cell Biology and Tumors Using Drosophila Genetics. Annu Rev Genet 47: 51-74. doi: 10.1146/annurev-genet-110711-155414
    [89] Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009. doi: 10.1016/j.cell.2011.11.016
    [90] Ma X, Shao Y, Zheng H, et al. (2013) Src42A modulates tumor invasion and cell death via Ben/dUev1a-mediated JNK activation in Drosophila. Cell Death Dis 4: e864. doi: 10.1038/cddis.2013.392
    [91] Ma X, Yang L, Yang Y, et al. (2013) dUev1a modulates TNF-JNK mediated tumor progression and cell death in Drosophila. Dev Biol 380: 211-221. doi: 10.1016/j.ydbio.2013.05.013
    [92] Ma X, Li W, Yu H, et al. (2014) Bendless modulates JNK-mediated cell death and migration in Drosophila. Cell Death Differ 21: 407-415. doi: 10.1038/cdd.2013.154
    [93] Lamar JM, Stern P, Liu H, et al. (2012) The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci U S A 109: E2441-2450. doi: 10.1073/pnas.1212021109
    [94] Vidal M, Larson DE, Cagan RL (2006) Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis. Dev Cell 10: 33-44. doi: 10.1016/j.devcel.2005.11.007
    [95] Herranz H, Hong X, Cohen SM (2012) Mutual repression by bantam miRNA and Capicua links the EGFR/MAPK and Hippo pathways in growth control. Curr Biol 22: 651-657.
    [96] Srivastava A, Pastor-Pareja JC, Igaki T, et al. (2007) Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion. Proc Natl Acad Sci U S A 104: 2721-2726. doi: 10.1073/pnas.0611666104
    [97] Yuan M, Tomlinson V, Lara R, et al. (2008) Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15: 1752-1759. doi: 10.1038/cdd.2008.108
    [98] Lucas EP, Khanal I, Gaspar P, et al. (2013) The Hippo pathway polarizes the actin cytoskeleton during collective migration of Drosophila border cells. J Cell Biol 201: 875-885. doi: 10.1083/jcb.201210073
    [99] Lin TH, Yeh TH, Wang TW, et al. (2014) The Hippo Pathway Controls Border Cell Migration Through Distinct Mechanisms in Outer Border Cells and Polar Cells of the Drosophila Ovary. Genetics 198: 1087-1099. doi: 10.1534/genetics.114.167346
    [100] Llense F, Martin-Blanco E (2008) JNK signaling controls border cell cluster integrity and collective cell migration. Curr Biol 18: 538-544. doi: 10.1016/j.cub.2008.03.029
    [101] Kulshammer E, Uhlirova M (2013) The actin cross-linker Filamin/Cheerio mediates tumor malignancy downstream of JNK signaling. J Cell Sci 126: 927-938. doi: 10.1242/jcs.114462
    [102] Rauskolb C, Sun S, Sun G, et al. (2014) Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex. Cell 158: 143-156. doi: 10.1016/j.cell.2014.05.035
    [103] Fernandez BG, Jezowska B, Janody F (2014) Drosophila actin-Capping Protein limits JNK activation by the Src proto-oncogene. Oncogene 33: 2027-2039. doi: 10.1038/onc.2013.155
    [104] Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549. doi: 10.1038/nrc2694
    [105] Park HW, Guan KL (2013) Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol Sci 34: 581-589. doi: 10.1016/j.tips.2013.08.006
    [106] Bubici C, Papa S (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol 171: 24-37. doi: 10.1111/bph.12432
    [107] Gladstone M, Su TT (2011) Chemical genetics and drug screening in Drosophila cancer models. J Genet Genomics 38: 497-504. doi: 10.1016/j.jgg.2011.09.003
    [108] Gonzalez C (2013) Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer 13: 172-183. doi: 10.1038/nrc3461
  • This article has been cited by:

    1. X Ma, Y Chen, S Zhang, W Xu, Y Shao, Y Yang, W Li, M Li, L Xue, Rho1–Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila, 2016, 35, 0950-9232, 846, 10.1038/onc.2015.137
    2. X Ma, W Xu, D Zhang, Y Yang, W Li, L Xue, Wallenda regulates JNK-mediated cell death in Drosophila, 2015, 6, 2041-4889, e1737, 10.1038/cddis.2015.111
    3. Brandon Dunn, Xianjue Ma, The dark side of hippo signaling: A cancer promoter role, 2017, 11, 1933-6934, 271, 10.1080/19336934.2017.1336270
    4. Helena E. Richardson, Drosophila models of cancer, 2015, 02, 2377-1143, 097, 10.3934/genet.2015.1.97
  • Reader Comments
  • © 2014 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6845) PDF downloads(1091) Cited by(4)

Article outline

Figures and Tables

Figures(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog